As healthcare professionals, it is crucial to understand the complexities of Parkinson's Disease (PD), a neurodegenerative disorder that has far-reaching implications on the quality of life of patients.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to a dopamine deficit in the striatum. While the exact cause remains unknown, both genetic and environmental factors are believed to play a role.
PD presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. Non-motor symptoms, including cognitive impairment, mood disorders, and autonomic dysfunction, may precede motor symptoms and significantly impact a patient's life.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging techniques can provide supportive evidence but are not diagnostic.
Management of PD is symptomatic, focusing on improving quality of life. Pharmacological treatment principally involves dopamine replacement or mimicking its effects. Non-pharmacological interventions include physical therapy and deep brain stimulation.
PD is a progressive disease with no cure. However, advancements in research are promising, with ongoing studies exploring neuroprotective strategies and disease-modifying therapies.
Understanding PD's complexity is key to providing comprehensive care to patients. As healthcare professionals, we must stay updated on the latest research developments to improve patient outcomes. Continued focus on patient-centered care, encompassing not just the motor symptoms but also the non-motor manifestations of PD, will ensure a holistic approach to management.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation